FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

703803006: Mirabegron (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3009012018 Mirabegron en Synonym Active Entire term case insensitive SNOMED CT core module
3009836015 Mirabegron (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirabegron Is a Substance with beta adrenergic receptor agonist mechanism of action false Inferred relationship Existential restriction modifier
Mirabegron Has disposition Beta adrenergic receptor agonist false Inferred relationship Existential restriction modifier
Mirabegron Has disposition Beta-3 adrenergic receptor agonist true Inferred relationship Existential restriction modifier
Mirabegron Is a Substance with beta-3 adrenergic receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing mirabegron Has active ingredient True Mirabegron Inferred relationship Existential restriction modifier 1
Mirabegron 25mg m/r tablet Has active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg m/r tablet Has active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Product containing mirabegron in oral dose form (medicinal product form) Has active ingredient True Mirabegron Inferred relationship Existential restriction modifier 1
Product containing precisely mirabegron 50 milligram/1 each prolonged-release oral tablet Has basis of strength substance True Mirabegron Inferred relationship Existential restriction modifier 1
Product containing precisely mirabegron 50 milligram/1 each prolonged-release oral tablet Has precise active ingredient True Mirabegron Inferred relationship Existential restriction modifier 1
Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet Has basis of strength substance True Mirabegron Inferred relationship Existential restriction modifier 1
Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet Has precise active ingredient True Mirabegron Inferred relationship Existential restriction modifier 1
Mirabegron Has active ingredient True Mirabegron Inferred relationship Existential restriction modifier 1
Product containing only mirabegron in oral dose form (medicinal product form) Has active ingredient True Mirabegron Inferred relationship Existential restriction modifier 1
Betmiga 50mg modified-release tablets (Ethigen Ltd) Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Ethigen Ltd) 30 tablet Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Pharmaram Ltd) Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 25mg modified-release tablets (Pharmaram Ltd) 30 tablet Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 25mg modified-release tablets (Pharmaram Ltd) Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Pharmaram Ltd) 30 tablet Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 25mg modified-release tablets Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg modified-release tablets Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (DE Pharmaceuticals) 30 tablet Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (DE Pharmaceuticals) Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 25mg modified-release tablets Has specific active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg modified-release tablets Has specific active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 25mg modified-release tablets 30 tablet Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg modified-release tablets 30 tablet Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 25mg modified-release tablets (Astellas Pharma Ltd) Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 25mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 25mg modified-release tablets Has active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg modified-release tablets Has active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) Has active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 25mg modified-release tablets (Astellas Pharma Ltd) Has active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg m/r tablet Has specific active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 25mg m/r tablet Has specific active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Waymade Healthcare Plc) Has active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Waymade Healthcare Plc) Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Waymade Healthcare Plc) 30 tablet Has specific active ingredient True Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 25mg modified-release tablets Has active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg modified-release tablets Has active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 25mg modified-release tablets Has specific active ingredient False Mirabegron Inferred relationship Existential restriction modifier
Mirabegron 50mg modified-release tablets Has specific active ingredient False Mirabegron Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start